Treating insomnia: Current and investigational pharmacological approaches.
about
Control of sleep and wakefulnessEffect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studiesDistinct α subunit variations of the hypothalamic GABAA receptor triplets (αβγ) are linked to hibernating state in hamsters.Management of Hypnotic Discontinuation in Chronic Insomnia.The sleep relay--the role of the thalamus in central and decentral sleep regulation.Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects.Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial.The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a reviewNightly analyses of subjective and objective (actigraphy) measures of sleep in fibromyalgia syndrome: what accounts for the discrepancy?Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefit next-day performance.Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002.Non-neuronal, slow GABA signalling in the ventrobasal thalamus targets δ-subunit-containing GABA(A) receptorsNext-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjectsEfficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomniaEEG power spectra response to a 4-h phase advance and gaboxadol treatment in 822 men and women.Functional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABA(A) receptors expressed in Xenopus laevis oocytes.The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control StudyClinical Efficacy of Traditional Chinese Medicine, Suan Zao Ren Tang, for Sleep Disturbance during Methadone Maintenance: A Randomized, Double-Blind, Placebo-Controlled Trial.Critical appraisal of ramelteon in the treatment of insomnia.Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studiesEszopiclone: its use in the treatment of insomnia.Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics.Modulation of ion channels in clinical psychopharmacology: adults and younger people.Drugs for insomnia.The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis.Current Phase II investigational therapies for insomnia.The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors.Effectiveness of Benzodiazepine Receptor Agonists in the Treatment of Insomnia: An Examination of Response and Remission Rates.Context dependent benzodiazepine modulation of GABA(A) receptor opening frequencyRandomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people.Effect of microdialysis perfusion of 4,5,6,7-tetrahydroisoxazolo-[5,4-c]pyridine-3-ol in the perifornical hypothalamus on sleep-wakefulness: role of delta-subunit containing extrasynaptic GABAA receptors.Dissociating anxiolytic and sedative effects of GABAAergic drugs using temperature and locomotor responses to acute stress.Intestinal gaboxadol absorption via PAT1 (SLC36A1): modified absorption in vivo following co-administration of L-tryptophan.New guidelines for diagnosis and treatment of insomnia.Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep.Safranal enhances non-rapid eye movement sleep in pentobarbital-treated mice.Triphlorethol A, a Dietary Polyphenol from Seaweed, Decreases Sleep Latency and Increases Non-Rapid Eye Movement Sleep in Mice.Low-dose doxepin (3 and 6 mg) for the treatment of insomnia
P2860
Q24634619-62B77577-12E8-4B08-9A18-4122D3AAD0A8Q33660498-B2B3235C-1843-4B37-92D9-7D607DBA1954Q33684096-F73E95FD-78B2-433B-9A96-5922AF84F692Q33958179-F69A70BE-4EE8-4730-94FC-0DD03EB9FCC0Q34215888-1439BE4D-5976-4FE2-825B-27CBFCC2DBAEQ34238302-2385918A-2A32-41B8-A61A-ABC73F8F3C11Q34623504-06954600-9CCE-4D83-87DC-2C5C302AE272Q34642390-41B75577-01AB-40AA-B13A-BA9293784A7DQ34743018-C804FD67-240A-418C-A68B-E53C89DC2743Q34770500-42118791-7B80-454C-8B29-5C0674FF5EE6Q34840661-DF70666D-7868-4BAA-A84B-EBC72DF28A24Q34983882-BC637249-F195-45AF-A6BC-F729F6677259Q35031754-2714B183-5E37-4E35-A16D-79507A2153E2Q35214361-DFF137C7-28AE-429B-B2FC-72744C9B6B94Q35217790-4692A3E8-DB5B-4A55-A16B-E970A3431873Q35311652-1F8E23B8-F446-4ED8-A227-D2F0C2AED484Q35583676-19D1FC16-EF84-4ED1-9BFB-47FACB1B11E7Q35782391-D09EEC78-0043-43BE-9B2A-954E5259BB6FQ35964019-6780AC19-3B54-4A19-8263-F0C7B5A61904Q36779840-72CC34B5-51C8-41DA-B460-CBDB0FFD75E7Q36948422-29E207A9-609D-46EB-87AE-9D547B1338B1Q37126802-AC7E31BD-6382-4450-A82F-42E38B162F12Q37639811-2BF9B8AD-AFB4-4185-88AA-B085281AD8AAQ37960095-7C93721F-7D9D-418C-9AC6-1329094A8F78Q38017272-6C233193-1077-4BA8-8DEC-FF70D31507FDQ38220445-A109FF4D-28D4-4B03-8AE4-5FE4D7F0ED41Q38271292-DB48F398-B2C0-4C10-8F39-BF063EEDBB06Q39365083-B8034324-2053-4CE4-A1A8-4182BCB64D81Q40264491-A1B0D955-20E0-4C4A-9EA6-4E0BA2E0F75AQ40434728-A1E115B8-E409-4484-A0F7-286569B030C2Q41001443-A96932E5-A39D-4FB3-919E-F5B0F1F73BB8Q41896998-06F5724C-9B01-42BC-A009-1623601916FEQ42567743-22C8610D-8684-43C4-A517-27E58141D9AAQ42589049-6B4C04D9-C213-45D8-B264-B99591883ABBQ42929690-69DFC91F-C4FB-49CE-9472-8301CAB4E3E8Q45987247-E5AC72B3-14FF-43E6-867C-93B0E6D8CAFEQ48242533-9ABA2B8D-9029-4FD1-B814-E3047A0751F9Q52563244-BC1BAF1D-F5EA-4327-94D0-70923231DEA5Q57487833-C9FDD87A-3703-4908-9149-D56F8CF7A0D1
P2860
Treating insomnia: Current and investigational pharmacological approaches.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Treating insomnia: Current and investigational pharmacological approaches.
@ast
Treating insomnia: Current and investigational pharmacological approaches.
@en
Treating insomnia: Current and investigational pharmacological approaches.
@nl
type
label
Treating insomnia: Current and investigational pharmacological approaches.
@ast
Treating insomnia: Current and investigational pharmacological approaches.
@en
Treating insomnia: Current and investigational pharmacological approaches.
@nl
prefLabel
Treating insomnia: Current and investigational pharmacological approaches.
@ast
Treating insomnia: Current and investigational pharmacological approaches.
@en
Treating insomnia: Current and investigational pharmacological approaches.
@nl
P2093
P1476
Treating insomnia: Current and investigational pharmacological approaches.
@en
P2093
Bjarke Ebert
Keith A Wafford
Stephen Deacon
P304
P356
10.1016/J.PHARMTHERA.2005.04.014
P577
2006-07-28T00:00:00Z